Eric Lund is the founder and CEO of MedSource. Since 1997, Mr. Lund has directed the growth and success of MedSource as the company created definitive solutions for serving the research community. Since its inception, the company has steadily expanded with offices now in Houston, Raleigh and San Diego and plans are set to open a location in Boston in 2015.
Mr. Lund has more than 20 years of experience in the biopharmaceutical industry at all levels of management. Under his leadership and direction, MedSource has grown into a full-service CRO known for its oncology expertise and quality services. It has been recognized several times by Inc. 500 and the Houston 100 as one of the fastest growing privately held companies and has also been an Eli Lilly Quality Advocate Award winner. Most recently, MedSource was given a CRO Leadership Award by Life Science Leader magazine.
Mr. Lund is a member of numerous industry organizations and currently serves on the Board of Trustees at Malone University.
Chris Clark joined Medsource in April 2016 as Chief Financial Officer and has overall responsibility for Finance, HR and IT.
Prior to joining Medsource, Chris spent the previous 6 years in senior financial leadership roles within the CRO sector, where he was instrumental in growing, selling and integrating two niche CROs (Nexus Oncology Ltd to Ockham in 2012; and Ockham to Chiltern International Ltd in 2014).
As CFO of North America for Chiltern, Chris had dual responsibility for the strategic direction and operations of the global staffing division and the North American finance function, in addition to playing a leading role in the acquisition and integration of Theorem Clinical Research, in the latter part of 2015.
Chris trained with Ernst & Young in the early part of his career before joining Ardana plc, a start-up specialty pharmaceutical business in 2003 where he supported the company through a number of private funding rounds and helped oversee the company’s successful listing on the London Stock Exchange in 2005.
Chris graduated from the University of Aberdeen, UK with a Masters in Economics and Management Studies. He is currently located in the UK office, in Edinburgh.
Matthew joined MedSource in 2013 as the Director of Corporate Operations & Development where his responsibilities span corporate and business operations functions including key areas of business development, marketing, strategic planning, technology development, as well as oversight of facilities management, human resources, and quality assurance. Prior to joining MedSource, Matthew came from McKesson/US Oncology where he held several management positions in operations and business development and led the launch and management of their CRO business unit.
Prior to managing the CRO business unit, he directed clinical research development for the Lung, GI, Hematology, and Radiation Oncology research programs. He has also held other research positions at the University of Texas Medical Branch in Galveston in the department of Orthopedic Surgery and MD Anderson Cancer Center in the department of Radiation Oncology. Matthew received his degree in biomedical science from Texas A&M University. Since starting his career in research, he has worked in key sections of basic and clinical research from bench to bedside to management.
Karen Kuhn joined in February 2017, bringing over 22 years of industry experience assuming the position of Senior Director Clinical Operations in our Raleigh, NC office. In her role here at MedSource Karen has overall responsibility for Project Management, Clinical Monitoring, Study Start-up, Regulatory Affairs and Biometrics as well as client support and relationships.
Prior to joining MedSource Karen has acquired extensive and varied industry knowledge and experience while working at both small to mid-size CROs, as well as a cooperative group and large pharmaceutical company. She is held positions from Research Associate to Global Project Manager and Project Director to Director of Project Management. Prior to moving into the research industry Karen was a Register Nurse working in both general oncology and Bone Marrow Transplant units.
Karen’s has successfully managed numerous studies including First in Man and Phase I-IV covering North America, both Eastern and Western Europe, and Asia Pacific regions. As Project Director, she has successfully managed two global oncology studies from start-up through to FDA submission and approval. Her therapeutic expertise is primarily hematology/oncology but also includes rare disease indications.
Doris Sanchez oversees the Scientific Development team at MedSource and is a point of escalation to sponsors for services contracted under this team. Ms. Sanchez brings to the team over 21 years of clinical research and development experience. She has experience in both large CRO and pharmaceutical sponsor environments as well as niche CRO and biotech. While her career focus is in oncology, she has experience a number of indications and assets that are in niche and complex patient populations. Ms. Sanchez also has experience across all phases of research and study designs and has thrived in creative and complex designs with the potential to accelerate a program. In her career, she has excelled across clinical research and development functions from CRA to study management and clinical research scientist work to the most recent success of overseeing a large cross functional senior team and building a framework and development strategy for an oncology pipeline and delivering the flagship INDs on time. Ms. Sanchez’s diverse clinical research and development experience will contribute to the success to sponsors’ programs.
Jennifer Delaney brings over 15 years of experience joining the MedSource team in 2007 where she currently leads our contracts and finance department in our Houston corporate office. Jennifer joined MedSource in 2007 and has various operational responsibilities which include overall management of finance and contracts, proposal and budget development, and identifying/integrating company technology systems. She has a broad background in the research industry including key roles in regulatory affairs and research laboratories. Jennifer graduated from the University of Houston Clear Lake with a BS in Biology and a MS in Biotechnology.
Jancarlo Durand joined MedSource in October 2016 and he serves as an Information Technology Manager. Jancarlo is located in the Raleigh, NC office and manages the infrastructure, network, telephony, support, and IT Architecture for the company. Additionally, Jancarlo acts a primary advisor to the CFO for technology-related engagements. He has over 8 years of experience in IT infrastructure in various industries such as Technology, Financial, and Retail.
Prior to joining Medsource, Jancarlo worked as Head of IT infrastructure for a Global organization where he led the efforts and implementation of SaaS, PaaS and IaaS technologies. Among other technologies, He implemented cloud technologies with a primary focus on AWS. Jancarlo obtained his undergraduate degree in Business at North Carolina State University and has an Advertising degree from IPP (Instituto Peruano de Publicidad) in Peru.
Kelly joined Medsource in January 2017 as the Human Resources Manager. Kelly has over 12 years of diverse human resources and management experience focusing the past 4 years specializing in small to mid-size Clinical Research Organizations. She has extensive hands-on experience leading HR initiatives including policy design, compensation, performance management, benefits, recruiting, employee relations and compliance reporting.
Prior to joining MedSource Kelly was the Human Resources Manager at Cmed Inc. and Chiltern International where she provided both tactical and strategic guidance to help build the HR infrastructure through technology, compliance and people. Through these efforts Kelly was able to align the HR Department to meet the company’s goals and objectives.
Kelly attended U-Mass Dartmouth and is also certified through the Human Resource Certification Institute as a Human Resource Professional (PHR).
Jessica McCoy joined MedSource in July 2016 and is the Manager of the Study Start-Up & Regulatory Affairs Department. She is based out of our Raleigh office location and leads the feasibility, site identification, trial master file, and site start-up/activation teams. In addition to participating in the strategic development and planning of overall clinical operations, Jessica assists with the general management of the Raleigh office. She has over 10 years of experience in management of study start-up and regulatory affairs for Phase I-IV global clinical research trials within the CRO industry. Jessica has extensive experience in hematology/oncology and central nervous system studies as well as other various complex disease indications.
Prior to joining MedSource, Jessica worked at various Clinical Research Organizations where she played a key role in strategy and timeline development of global clinical trials. This included but was not limited to proposal progression, study start-up implementation, facilitation of ethics committee and regulatory submissions, contract negotiations, delivery of study milestones, and overall project execution. Jessica also has several years of experience in training and mentoring project team members. She began her career in clinical research as a Study Coordinator after finishing her undergraduate degree at Miami University of Ohio.
Marcia Phillips joined MedSource in September 2015 as the Quality Assurance Manager where she leads the Quality Assurance Department from our Raleigh office location. Marcia has over 20 years’ experience in regulated life science industry with a diverse background in Quality Assurance. Prior to MedSource, Marcia worked for several contract research organizations in the Research Triangle area where she developed a depth of knowledge in GxPs and their application to regulatory research and development. Her experience assists the MedSource team in delivering quality, compliant products and services to our clients.
She began her Quality Assurance career in the agrochemical industry before transitioning to preclinical pharmaceuticals, followed by clinical trial research. She received degrees from Pennsylvania State University (Wildlife Sciences), New Mexico State University (Wildlife Sciences with a Minor in Toxicology), and East Carolina University (History).
Tao Feng joined MedSource in June 2017 as the Principal Biostatistician. He attended University of Southern California, where he earned his PhD and Masters of Science while majoring in biostatistics. He has extensive experience in biostatistics analysis in both industrial clinical trials and academic clinical research. His methodology for clinical trial design covers both Frequentist and Bayesian approaches.
Prior to joining MedSource, he was a Lead Biostatistician at a large CRO where he led Phase I to III clinical trials. As Lead Biostatistician, his responsibilities included writing statistical analysis plans for various projects and reports. He has a wide range of experience in SAS programming, validation, data transfers and working with clinical SAS programmers to ensure the accuracy of summary tables, listings, and graphs. He has experience with database management, creating biostatistics databases, investigating and clarifying data issues, managing biostatistics timelines and coordinating and validating the data transfer processes. He also has experience tracking and managing project budgets, developing bids and contract modification costs, reviewing medical writing reports, assisting with protocol development by writing the statistical portions, reviewing protocols for consistency, providing sample size calculations, performing simulations to help clients understand a project, submitting IND supplemental statistical sections to FDA, and upholding DSMB Guidelines on all projects. He was also a technical consultant of a Bayesian Analysis Initiative and helped biostatisticians to design, execute and report on Bayesian Analysis supporting Phase I-III clinical trials.
In the past, he worked as a lead biostatistician for the medical oncology department at City of Hope National Medical Center. While there, he led all biostatistics analyses and activities on phase IV clinical research for the Cancer and Aging Research Group and published about 20 papers in the top peer review journals.